Year |
Citation |
Score |
2024 |
Chiu TY, Lazar DC, Wang WW, Wozniak JM, Jadhav AM, Li W, Gazaniga N, Theofilopoulos AN, Teijaro JR, Parker CG. Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity. Nature Chemical Biology. PMID 38191941 DOI: 10.1038/s41589-023-01527-8 |
0.625 |
|
2020 |
Chin EN, Yu C, Vartabedian VF, Jia Y, Kumar M, Gamo AM, Vernier W, Ali SH, Kissai M, Lazar DC, Nguyen N, Pereira LE, Benish B, Woods AK, Joseph SB, et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science (New York, N.Y.). 369: 993-999. PMID 32820126 DOI: 10.1126/Science.Abb4255 |
0.63 |
|
2020 |
Vinogradova EV, Zhang X, Remillard D, Lazar DC, Suciu RM, Wang Y, Bianco G, Yamashita Y, Crowley VM, Schafroth MA, Yokoyama M, Konrad DB, Lum KM, Simon GM, Kemper EK, et al. An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells. Cell. PMID 32730809 DOI: 10.1016/J.Cell.2020.07.001 |
0.663 |
|
2019 |
Zaro BW, Vinogradova EV, Lazar DC, Blewett MM, Suciu RM, Takaya J, Studer S, de la Torre JC, Casanova JL, Cravatt BF, Teijaro JR. Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4-MyD88 Complex. Journal of Immunology (Baltimore, Md. : 1950). PMID 30885957 DOI: 10.4049/Jimmunol.1801627 |
0.676 |
|
2018 |
Shaabani N, Honke N, Nguyen N, Huang Z, Arimoto KI, Lazar D, Loe TK, Lang KS, Prinz M, Knobeloch KP, Zhang DE, Teijaro JR. The probacterial effect of type I interferon signaling requires its own negative regulator USP18. Science Immunology. 3. PMID 30266866 DOI: 10.1126/Sciimmunol.Aau2125 |
0.598 |
|
2018 |
Zhou J, Lazar D, Li H, Xia X, Satheesan S, Charlins P, O'Mealy D, Akkina R, Saayman S, Weinberg MS, Rossi JJ, Morris KV. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1. Theranostics. 8: 1575-1590. PMID 29556342 DOI: 10.7150/Thno.23085 |
0.358 |
|
2015 |
Saayman SM, Lazar DC, Scott TA, Hart JR, Takahashi M, Burnett JC, Planelles V, Morris KV, Weinberg MS. Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26581162 DOI: 10.1038/Mt.2015.202 |
0.395 |
|
2015 |
Saayman SM, Lazar DC, Scott TA, Burnett J, Takahashi M, Weinberg MS, Morris KV. 693. Potent and Targeted Activation of Latent HIV-1 Using Multiplexed Guide RNAs and the CRISPR/dCas9 Activator Complex Molecular Therapy. 23: S276. DOI: 10.1016/S1525-0016(16)34302-7 |
0.349 |
|
2015 |
Scott T, Saayman S, Lazar D, Arbuthnot P, Rigoutsos I, Morris K, Kashanchi F, Weinberg M. 119. HIV-1 Proviral DNA Excision and Deactivation Using a CRISPR/Cas9 “Nickase” Targeted to the 5’ and 3’ LTR Molecular Therapy. 23: S49-S50. DOI: 10.1016/S1525-0016(16)33724-8 |
0.353 |
|
2015 |
Lazar DC, Zhou J, Saayman S, Rossi JJ, Morris KV, Weinburg MS. 62. Aptamer-siRNA Conjugate Directed Transcriptional Gene Silencing in HIV-1 Infected T Cells Molecular Therapy. 23: S27-S28. DOI: 10.1016/S1525-0016(16)33667-X |
0.369 |
|
2012 |
Gross ME, Lazar D, Cho EH, Luttgen M, Metzner T, Uson ML, Torrey ML, Kuhn P. Non-enrichment-based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate-resistant prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 194. PMID 27968136 DOI: 10.1200/Jco.2012.30.5_Suppl.194 |
0.356 |
|
2012 |
Lazar DC, Cho EH, Luttgen MS, Metzner TJ, Uson ML, Torrey M, Gross ME, Kuhn P. Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line. Physical Biology. 9: 016002. PMID 22306736 DOI: 10.1088/1478-3975/9/1/016002 |
0.319 |
|
2012 |
Gross ME, Lazar DC, Cho EH, Luttgen M, Uson ML, Kuhn P, Torrey ML. Abstract 3630: Non-enrichment based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate resistant prostate cancer Cancer Research. 72: 3630-3630. DOI: 10.1158/1538-7445.Am2012-3630 |
0.322 |
|
2012 |
Metzner TJ, Bethel K, Cho EH, Luttgen MS, Lazar DC, Uson ML, Nieva JJ, Bazhenova L, Kolatkar A, Kuhn P. Abstract 3619: The absence of cleaved caspase-3 in circulating tumor cells detected using a non-enrichment-based assay Cancer Research. 72: 3619-3619. DOI: 10.1158/1538-7445.Am2012-3619 |
0.352 |
|
2010 |
Marrinucci D, Bethel K, Lazar D, Fisher J, Huynh E, Clark P, Bruce R, Nieva J, Kuhn P. Cytomorphology of circulating colorectal tumor cells:a small case series. Journal of Oncology. 2010: 861341. PMID 20111743 DOI: 10.1155/2010/861341 |
0.313 |
|
2009 |
Luttgen MS, Marrinucci D, Lazar D, Malchiodi M, Clark P, Huynh E, Bethel K, Bazhenova L, Nieva J, Kuhn P. Circulating tumor cells monitored over time in lung cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11025. PMID 27963968 DOI: 10.1200/Jco.2009.27.15_Suppl.11025 |
0.303 |
|
Show low-probability matches. |